trans-aconitic acid, min. 98.0%, 10 g, plastic packaging.

4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-ol, 98%, 25g

3-Fluoro-5-methylbenzotrilfuoride, 98.0%, 250mg

DIETHYL (3-THIENYL)MALONATE, 95.0%, 1g

3-Chlorobenzo[d]isothiazole, 95.0%, 1g

3-methyl-1H-indazole hydrochloride, 95.0%, 5g

2-Chloro-5,6-dimethyl-1H-benzo[d]imidazole, 97%, 1g

Methyl 4-methoxy-3,5-dimethylpicolinate, 95+%, 250mg

(1S,2S,3R,4R)-3-(TERT-BUTOXYCARBONYLAMINO)BICYCLO[2.2.1]HEPT-5-ENE-2-CARBOXYLIC ACID, 95%, 100mg

6-Fluoro-2,3-dimethoxybenzaldehyde, 98%, 5g

2-(3-Fluoro-4-((methylsulfonyl)methyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95%, 1g

(1S,2S)-(-)-1,2-DIAMINOCYCLOHEXANE-N,N'-BIS(2'-DIPHENYLPHOSPHINOBENZOYL), 97%, 1g

(R)-1-(3-(Trifluoromethyl)phenyl)ethanamine, 96.0%, 250mg